Changes in cerebral metabolism are detected prior to perfusion changes in early HIV‐CMC: A coregistered 1H MRS and SPECT study

Human immunodeficiency virus‐cognitive motor complex (HIV‐CMC), a common complication of the acquired immunodeficiency syndrome (AIDS), is characterized by progressive cognitive impairment and motor dysfunction. Functional imaging methods, such as single‐photon emission computed tomography ( SPECT ) and proton magnetic resonance spectroscopy (1H‐MRS), have been applied to assess the severity of brain injury. However, it is unclear which of these two methods is more sensitive in detecting brain abnormalities in patients with early HIV‐CMC. Twenty‐four HIV‐CMC patients were compared with 34 healthy subjects; each had quantitative SPECT (133Xenon‐calibrated 99mTc‐HMPAO) and quantitative 1H‐MRS. Both modalities were co‐registered in order to assess regional cerebral blood flow (rCBF) and metabolite concentrations within the same voxel of interest in four brain regions (midfrontal and midparietal gray matter, temporoparietal white matter, and basal ganglia). On SPECT, only the temporoparietal white matter showed a trend for decreased rCBF in HIV‐CMC patients (−13%, P = 0.06). On MRS, HIV‐CMC patients showed significantly reduced creatine concentration in the basal ganglia (−8%, P = 0.008), as well as increased myoinositol concentrations in the basal ganglia (+25%, P = 0.01) and the temporoparietal white matter (+18%, P = 0.08). There was no significant correlation between SPECT and MRS variables in the patients in any region. 1H MRS showed abnormal neurochemistry in the basal ganglia, whereas rCBF on SPECT was normal in the same region. This finding suggests that metabolite concentrations on 1H MRS are better surrogate markers than rCBF measurements with SPECT for the evaluation of brain injury in early HIV‐CMC. J. Magn. Reson. Imaging 2000;12:859–865. © 2000 Wiley‐Liss, Inc.

[1]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[2]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[3]  Laurent Itti,et al.  Improved 3D correction for partial volume effects in brain SPECT , 1997, Human brain mapping.

[4]  Francesco Scaravilli,et al.  Neuropathology of Early HIV‐1 Infection , 1996, Brain pathology.

[5]  J. Sidtis,et al.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.

[6]  Oliver Speck,et al.  Perfusion MRI detects rCBF abnormalities in early stages of HIV–cognitive motor complex , 2000, Neurology.

[7]  I Kanno,et al.  Two Methods for Calculating Regional Cerebral Blood Flow from Emission Computed Tomography of Inert Gas Concentrations , 1979, Journal of computer assisted tomography.

[8]  O. Selnes,et al.  Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men , 1999, Neurology.

[9]  G. Leinsinger,et al.  Reduced cerebral blood flow in early stages of human immunodeficiency virus infection. , 1990, Archives of neurology.

[10]  E. Aylward,et al.  Regional brain atrophy in HIV‐1 infection: association with specific neuropsychological test performance , 1993, Acta neurologica Scandinavica.

[11]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.

[12]  T. Crawford,et al.  Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood‐brain barrier , 1993, Annals of neurology.

[13]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[14]  B D Ross,et al.  Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols , 1991, NMR in biomedicine.

[15]  J. Hennig,et al.  HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. , 1996, Radiology.

[16]  R. V. Van Heertum,et al.  Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Glass,et al.  Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia. , 1996, Journal of neuropathology and experimental neurology.

[18]  M. Devous,et al.  Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[20]  B. Navia,et al.  The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.

[21]  T. Ernst,et al.  Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe , 1996, Magnetic resonance in medicine.

[22]  Serial studies of cerebral blood flow using 99Tcm-HMPAO: a comparison with 133Xe. , 1987, Nuclear medicine communications.

[23]  E. Kendall.  The adrenal cortex and rheumatoid arthritis. , 1951, British medical journal.

[24]  H. Mamo,et al.  Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  J. Mills,et al.  ISOLATION OF AIDS-ASSOCIATED RETROVIRUSES FROM CEREBROSPINAL FLUID AND BRAIN OF PATIENTS WITH NEUROLOGICAL SYMPTOMS , 1985, The Lancet.

[26]  R. Lenkinski,et al.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Bredesen,et al.  Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. , 1985, Journal of neurosurgery.

[28]  D. Katzenstein,et al.  Issues in the evaluation of AIDS vaccines. , 1988, AIDS (London).

[29]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  J F Mangin,et al.  Robust multimodality registration for brain mapping , 1997, Human brain mapping.

[31]  P. Barker,et al.  AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.

[32]  L. Prockop.  AIDS dementia complex. , 1988, The Journal of legal medicine.

[33]  S C Strother,et al.  Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[35]  H. Gendelman,et al.  Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. , 1994, AIDS research and human retroviruses.

[36]  F. Gerstenbrand,et al.  Single photon emission computed tomography in AIDS dementia complex. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  J. Mendelson,et al.  A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  C. Kirsch,et al.  Functional and Morphological Findings in Early and Advanced Stages of HIV Infection: a Comparison of 99mTc-HMPAO SPECT with CT and MRI Studies , 1990, Nuklearmedizin.

[39]  F. Pau,et al.  Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV‐1-infected subjects , 1992, AIDS.

[40]  D. Bates,et al.  SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. , 1994, AJR. American journal of roentgenology.

[41]  G D Pearlson,et al.  Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. , 1995, The American journal of psychiatry.

[42]  F. Ferraro,et al.  Acquired immunodeficiency syndrome dementia complex. , 1997, Journal of clinical psychology.

[43]  S. Strother,et al.  The metabolic pathology of the AIDS dementia complex , 1987, Annals of neurology.

[44]  A. J. Kumar,et al.  Patterns of cerebral atrophy in HIV–1–infected individuals , 1992, Neurology.

[45]  Bruce J. Brew,et al.  The management of the neurological complications of HIV infection and AIDS. , 1988, AIDS.

[46]  L. Chang,et al.  Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex , 1999, Neurology.

[47]  B Marc,et al.  Early Brain Changes in HIV Infection: Neuropathological Study of 11 HIV Seropositive, Non‐AIDS Cases , 1992, Journal of neuropathology and experimental neurology.

[48]  R. V. Van Heertum,et al.  A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment. , 1995, Archives of neurology.

[49]  M. McGrath,et al.  Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. , 1991, The Journal of clinical investigation.

[50]  A. Guimarães,et al.  Increased cerebral blood volume in HIV‐positive patients detected by functional MRI , 1998, Neurology.

[51]  L. Chang,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[52]  D. Menon,et al.  Proton MR Spectroscopy of the Brain in AIDS Dementia Complex , 1992, Journal of computer assisted tomography.

[53]  G. Pearlson,et al.  Altered cortical blood flow in HIV‐seropositive individuals with and without dementia: a single photon emission computed tomography study , 1994, AIDS.

[54]  J. McArthur,et al.  Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.

[55]  R. Janssen,et al.  Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV‐infected persons , 1998, Neurology.

[56]  Andrew J. Saykin,et al.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.

[57]  R. Lenkinski,et al.  Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. , 1993, Radiology.

[58]  P. Lantos,et al.  Neuronal loss in the frontal cortex in HIV infection , 1991, The Lancet.

[59]  I. Wilkinson,et al.  Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. , 1993, Radiology.